APPLICATION
NDA018025
TYPE
NDA
ORIGINAL APPROVAL
1979-01-10
LATEST ACTION
2002-10-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 10MG/ML · INJECTABLE · INJECTION
Approval history
2002-10-21Manufacturing (CMC) · Supplement 34AP
1999-09-17Labeling · Supplement 33AP
1998-03-05Labeling · Supplement 32AP
1998-01-14Manufacturing (CMC) · Supplement 28AP
1995-09-19Manufacturing (CMC) · Supplement 31AP
1994-06-17Manufacturing (CMC) · Supplement 29AP
1994-06-07Manufacturing (CMC) · Supplement 30AP
1993-10-29Manufacturing (CMC) · Supplement 27AP
1992-12-17Manufacturing (CMC) · Supplement 26AP
1992-04-29Labeling · Supplement 23AP
1992-03-17Labeling · Supplement 24AP
1992-03-17Labeling · Supplement 25AP
1991-03-15Labeling · Supplement 22AP
1987-05-01Manufacturing (CMC) · Supplement 18AP
1985-06-13Manufacturing (CMC) · Supplement 11AP
1985-05-08Manufacturing (CMC) · Supplement 10AP
1979-01-10OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.